Comparison of 25 and 50μg vaginally administered misoprostol for preinduction of cervical ripening and labor induction

Recep Has, Cem Batukan, Hayri Ermis, Erdal Cevher, Ahmet Araman, Gokhan Kilic, Lem'i Ibrahimoǧlu

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Our purpose was to compare the efficacy of 25 μg and 50 μg intravaginally administered misoprostol tablets for cervical ripening and labor induction. Either 25-μg (n: 58) or 50-μg (n: 56) misoprostol tablets were randomly administered intravaginally to 114 subjects with an unripe cervix for labor induction. The physician was blinded to the medication. Intravaginal misoprostol was given every 4 h until the onset of labor. The mean Bishop score before misoprostol administration was 2.1 ± 1.6 in the 25-μg group and 2.0 ± 1.4 in the 50-μg group (p > 0.05). With the 25-μg dose the time until delivery was significantly longer (991.2 ± 514.4 min vs. 703.12 ± 432.6 min in the 50-μg group). The use of oxytocin augmentation was significantly higher in the 25-μg group (63.8%) than the 50-μg group (32.1%; p < 0.05). The proportions of patients with tachysystoles and hypersystoles were not significantly different between the two groups (19 and 6.9%, respectively, in the 25-μg group and 25 and 17.8%, respectively, in 50-μg group; p > 0.05). Overall, in the 25-μg group more women achieved vaginal delivery (79.3 vs. 60.7%; p < 0.05). The rate of cesarean sections due to nonreassuring fetal status was higher in the 50-μg misoprostol group (28.6 vs. 10.3%; p < 0.05). The number of neonates with a low 1-min Apgar score (< 7) was significantly higher in the 50-μg misoprostol group (26.8 vs. 8.6%; p < 0.05), but 5-min Apgar scores and umbilical artery blood gas values at the time of delivery were not significantly different between the groups (p > 0.05). One patient in the 25-μg group suffered a ruptured uterus. Intravaginal administration of 25 μg of misoprostol is a clinically effective labor induction regimen and has the least adverse effects and complications.

Original languageEnglish (US)
Pages (from-to)16-21
Number of pages6
JournalGynecologic and Obstetric Investigation
Volume53
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Cervical Ripening
Induced Labor
Misoprostol
Tablets
Intravaginal Administration
Labor Onset
Oxytocin
Cervix Uteri
Uterus
Physicians

Keywords

  • Cervical ripening
  • Labor induction
  • Misoprostol

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Comparison of 25 and 50μg vaginally administered misoprostol for preinduction of cervical ripening and labor induction. / Has, Recep; Batukan, Cem; Ermis, Hayri; Cevher, Erdal; Araman, Ahmet; Kilic, Gokhan; Ibrahimoǧlu, Lem'i.

In: Gynecologic and Obstetric Investigation, Vol. 53, No. 1, 2002, p. 16-21.

Research output: Contribution to journalArticle

Has, Recep ; Batukan, Cem ; Ermis, Hayri ; Cevher, Erdal ; Araman, Ahmet ; Kilic, Gokhan ; Ibrahimoǧlu, Lem'i. / Comparison of 25 and 50μg vaginally administered misoprostol for preinduction of cervical ripening and labor induction. In: Gynecologic and Obstetric Investigation. 2002 ; Vol. 53, No. 1. pp. 16-21.
@article{d06caa08d0664882b259e434fb041486,
title = "Comparison of 25 and 50μg vaginally administered misoprostol for preinduction of cervical ripening and labor induction",
abstract = "Our purpose was to compare the efficacy of 25 μg and 50 μg intravaginally administered misoprostol tablets for cervical ripening and labor induction. Either 25-μg (n: 58) or 50-μg (n: 56) misoprostol tablets were randomly administered intravaginally to 114 subjects with an unripe cervix for labor induction. The physician was blinded to the medication. Intravaginal misoprostol was given every 4 h until the onset of labor. The mean Bishop score before misoprostol administration was 2.1 ± 1.6 in the 25-μg group and 2.0 ± 1.4 in the 50-μg group (p > 0.05). With the 25-μg dose the time until delivery was significantly longer (991.2 ± 514.4 min vs. 703.12 ± 432.6 min in the 50-μg group). The use of oxytocin augmentation was significantly higher in the 25-μg group (63.8{\%}) than the 50-μg group (32.1{\%}; p < 0.05). The proportions of patients with tachysystoles and hypersystoles were not significantly different between the two groups (19 and 6.9{\%}, respectively, in the 25-μg group and 25 and 17.8{\%}, respectively, in 50-μg group; p > 0.05). Overall, in the 25-μg group more women achieved vaginal delivery (79.3 vs. 60.7{\%}; p < 0.05). The rate of cesarean sections due to nonreassuring fetal status was higher in the 50-μg misoprostol group (28.6 vs. 10.3{\%}; p < 0.05). The number of neonates with a low 1-min Apgar score (< 7) was significantly higher in the 50-μg misoprostol group (26.8 vs. 8.6{\%}; p < 0.05), but 5-min Apgar scores and umbilical artery blood gas values at the time of delivery were not significantly different between the groups (p > 0.05). One patient in the 25-μg group suffered a ruptured uterus. Intravaginal administration of 25 μg of misoprostol is a clinically effective labor induction regimen and has the least adverse effects and complications.",
keywords = "Cervical ripening, Labor induction, Misoprostol",
author = "Recep Has and Cem Batukan and Hayri Ermis and Erdal Cevher and Ahmet Araman and Gokhan Kilic and Lem'i Ibrahimoǧlu",
year = "2002",
doi = "10.1159/000049405",
language = "English (US)",
volume = "53",
pages = "16--21",
journal = "Gynecologic and Obstetric Investigation",
issn = "0378-7346",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Comparison of 25 and 50μg vaginally administered misoprostol for preinduction of cervical ripening and labor induction

AU - Has, Recep

AU - Batukan, Cem

AU - Ermis, Hayri

AU - Cevher, Erdal

AU - Araman, Ahmet

AU - Kilic, Gokhan

AU - Ibrahimoǧlu, Lem'i

PY - 2002

Y1 - 2002

N2 - Our purpose was to compare the efficacy of 25 μg and 50 μg intravaginally administered misoprostol tablets for cervical ripening and labor induction. Either 25-μg (n: 58) or 50-μg (n: 56) misoprostol tablets were randomly administered intravaginally to 114 subjects with an unripe cervix for labor induction. The physician was blinded to the medication. Intravaginal misoprostol was given every 4 h until the onset of labor. The mean Bishop score before misoprostol administration was 2.1 ± 1.6 in the 25-μg group and 2.0 ± 1.4 in the 50-μg group (p > 0.05). With the 25-μg dose the time until delivery was significantly longer (991.2 ± 514.4 min vs. 703.12 ± 432.6 min in the 50-μg group). The use of oxytocin augmentation was significantly higher in the 25-μg group (63.8%) than the 50-μg group (32.1%; p < 0.05). The proportions of patients with tachysystoles and hypersystoles were not significantly different between the two groups (19 and 6.9%, respectively, in the 25-μg group and 25 and 17.8%, respectively, in 50-μg group; p > 0.05). Overall, in the 25-μg group more women achieved vaginal delivery (79.3 vs. 60.7%; p < 0.05). The rate of cesarean sections due to nonreassuring fetal status was higher in the 50-μg misoprostol group (28.6 vs. 10.3%; p < 0.05). The number of neonates with a low 1-min Apgar score (< 7) was significantly higher in the 50-μg misoprostol group (26.8 vs. 8.6%; p < 0.05), but 5-min Apgar scores and umbilical artery blood gas values at the time of delivery were not significantly different between the groups (p > 0.05). One patient in the 25-μg group suffered a ruptured uterus. Intravaginal administration of 25 μg of misoprostol is a clinically effective labor induction regimen and has the least adverse effects and complications.

AB - Our purpose was to compare the efficacy of 25 μg and 50 μg intravaginally administered misoprostol tablets for cervical ripening and labor induction. Either 25-μg (n: 58) or 50-μg (n: 56) misoprostol tablets were randomly administered intravaginally to 114 subjects with an unripe cervix for labor induction. The physician was blinded to the medication. Intravaginal misoprostol was given every 4 h until the onset of labor. The mean Bishop score before misoprostol administration was 2.1 ± 1.6 in the 25-μg group and 2.0 ± 1.4 in the 50-μg group (p > 0.05). With the 25-μg dose the time until delivery was significantly longer (991.2 ± 514.4 min vs. 703.12 ± 432.6 min in the 50-μg group). The use of oxytocin augmentation was significantly higher in the 25-μg group (63.8%) than the 50-μg group (32.1%; p < 0.05). The proportions of patients with tachysystoles and hypersystoles were not significantly different between the two groups (19 and 6.9%, respectively, in the 25-μg group and 25 and 17.8%, respectively, in 50-μg group; p > 0.05). Overall, in the 25-μg group more women achieved vaginal delivery (79.3 vs. 60.7%; p < 0.05). The rate of cesarean sections due to nonreassuring fetal status was higher in the 50-μg misoprostol group (28.6 vs. 10.3%; p < 0.05). The number of neonates with a low 1-min Apgar score (< 7) was significantly higher in the 50-μg misoprostol group (26.8 vs. 8.6%; p < 0.05), but 5-min Apgar scores and umbilical artery blood gas values at the time of delivery were not significantly different between the groups (p > 0.05). One patient in the 25-μg group suffered a ruptured uterus. Intravaginal administration of 25 μg of misoprostol is a clinically effective labor induction regimen and has the least adverse effects and complications.

KW - Cervical ripening

KW - Labor induction

KW - Misoprostol

UR - http://www.scopus.com/inward/record.url?scp=0036157945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036157945&partnerID=8YFLogxK

U2 - 10.1159/000049405

DO - 10.1159/000049405

M3 - Article

C2 - 11803223

AN - SCOPUS:0036157945

VL - 53

SP - 16

EP - 21

JO - Gynecologic and Obstetric Investigation

JF - Gynecologic and Obstetric Investigation

SN - 0378-7346

IS - 1

ER -